Dergiler / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 2

Malignancy rates and histopathological subtypes in pediatric thyroidectomy: a retrospective analysis from Acıbadem University (2010–2025)

Mehmet Arda İnan(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-6179-2828
Eylem Akar(Acibadem Altunizade Hospital)0000-0003-4401-0182
Saygın Abalı(ACIBADEM UNIVERSITY, SCHOOL OF MEDICINE)0000-0001-6552-2801
Mete Düren(Acibadem Maslak Hospital)0000-0001-6670-0227
Demet Etit(Acibadem Maslak Hospital)0000-0002-6282-0173
Sayfa
—
Yayın Tarihi
2026-03-12
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The establishment of national or multicenter registries integrating clinical, pathological, and molecular data is essential to advance evidence-based management in pediatric thyroid cancer.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Pediatric thyroid tumors are rare entities with distinct biological behavior and clinicopathological features compared with adult thyroid neoplasms.
📊
Temel Bulgular & Veri:This study aimed to evaluate malignancy rates and histopathological subtypes in a large, single-center cohort of pediatric patients who underwent thyroidectomy, and to characterize the pathological spectrum of pediatric thyroid disease in a tertiary referral setting.
💡
Sonuç & Katkı:The establishment of national or multicenter registries integrating clinical, pathological, and molecular data is essential to advance evidence-based management in pediatric thyroid cancer.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2010 Verileri
⚙️Değişkenler:Thyroid neoplasms · pediatrics · papillary thyroid carcinoma

Abstract

Aims: Pediatric thyroid tumors are rare entities with distinct biological behavior and clinicopathological features compared with adult thyroid neoplasms. This study aimed to evaluate malignancy rates and histopathological subtypes in a large, single-center cohort of pediatric patients who underwent thyroidectomy, and to characterize the pathological spectrum of pediatric thyroid disease in a tertiary referral setting. Methods: This retrospective study included pediatric patients (≤18 years) who underwent partial or total thyroidectomy at Acıbadem Mehmet Ali Aydınlar University between January 2010 and October 2025. Clinical and pathological data were retrieved from institutional archives and electronic medical records. All histological slides were reviewed by two pathologists according to the World Health Organization classification of thyroid tumors. Tumors were categorized as benign or malignant, and malignant cases were subclassified by histopathological subtype. Pathological tumor–node–metastasis staging was performed according to the 8th edition of the American Joint Committee on Cancer TNM system. Descriptive statistics were used to summarize demographic and pathological findings. Results: A total of 174 pediatric thyroidectomy specimens were analyzed, of which 98 (56.3%) were malignant, 3 (1.7%) were low-risk neoplasms and 73 (42.0%) were benign. The cohort showed a marked female predominance, and most patients were adolescents at the time of surgery. Among malignant tumors, papillary thyroid carcinoma was the most frequent type, followed by less common differentiated and non-differentiated thyroid malignancies. Classical papillary thyroid carcinoma represented the predominant papillary subtype. Multifocal disease and regional lymph node metastasis were frequently observed at diagnosis, whereas distant metastasis was uncommon. Immunohistochemistry was applied selectively in a limited number of cases, with diagnosis primarily based on histopathological assessment. Pathological staging demonstrated a predominance of early T-stage primary tumors despite a high rate of nodal involvement. Conclusion: Pediatric thyroid tumors are rare entities with distinct biological behavior, frequently presenting with locoregional disease while maintaining an excellent prognosis. Papillary thyroid carcinoma remains the predominant malignant type, with histopathological evaluation serving as the diagnostic cornerstone and molecular characterization gaining increasing relevance. The establishment of national or multicenter registries integrating clinical, pathological, and molecular data is essential to advance evidence-based management in pediatric thyroid cancer.

🔖

Bu Makaleye Atıf Yap

İnan, M. A., Akar, E., Abalı, S., Çorapçıoğlu, F. V., Düren, M., Etit, D. (2026). Malignancy rates and histopathological subtypes in pediatric thyroidectomy: a retrospective analysis from Acıbadem University (2010–2025). Journal of Health Sciences and Medicine, Volume: 9 Issue: 2. https://doi.org/10.32322/jhsm.1857395

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (22)

  1. Cherella CE, Wassner AJ. Pediatric thyroid cancer: recent developments. Best Pract Res Clin Endocrinol Metab. 2023;37(1):101715. doi:10.1016/j.beem.2022.101715
  2. Republic of Türkiye Ministry of Health, General Directorate of Public Health, Cancer Department. Turkey cancer statistics 2020. Published 2020. Accessed December 1, 2025. https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/Dokumanlar/Istatistikler/Turkiye_Kanser_Istatistikleri_2020.pdf
  3. National Cancer Institute. SEER*Explorer: cancer statistics explorer network web application. Accessed December 13, 2025. https://seer.cancer.gov/statistics-network/explorer/application.html
  4. Moleti M, Aversa T, Crisafulli S, et al. Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1270518. doi:10.3389/fendo.2023.1270518
  5. Gao MZ, Omer TM, Miller KM, et al. Thyroid cancer incidence and trends in United States and Canadian pediatric, adolescent, and young adults. Cancers (Basel). 2025;17(9):1429. doi:10.3390/cancers17091429
  6. Puga FM, Correia L, Vieira I, et al. Differentiated thyroid cancer in children and adolescents: 12-year experience in a single center. J Clin Res Pediatr Endocrinol. 2024;16(3):314-322. doi:10.4274/jcrpe.galenos. 2024.2024-1-25
  7. Lee YA, Yun HR, Lee J, et al. Trends in pediatric thyroid cancer incidence, treatment, and clinical course in Korea during 2004–2016: a nationwide population-based study. Thyroid. 2021;31(6):902-911. doi:10. 1089/thy.2020.0155
  8. Parvathareddy SK, Siraj AK, Annaiyappanaidu P, et al. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia. Front Endocrinol (Lausanne). 2023;14:1228049. doi: 10.3389/fendo.2023.1228049
  9. Barsal Cetiner E, Donbaloglu Z, Bedel A, et al. Çocukluk çağında tiroidektomi yapılan hastaların değerlendirilmesi. Firat Med J. 2024; 29(3):148-154.
  10. Dagdeviren Cakir A, Turan H, Ercan O, Evliyaoglu O. Thyroid nodules in children and adolescents: a single institution’s experience. Turk Arch Pediatr. 2023;58(4):401-406. doi:10.5152/TurkArchPediatr.2023.22302
  11. Lebbink CA, Links TP, Czarniecka A, et al. 2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022;11(6):e220146. doi:10.1530/ETJ-22-0146
  12. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716-759. doi:10.1089/thy.2014.0460
  13. Kothari R, Donner JR, Balakrishnan K, et al. Composition and priorities of multidisciplinary pediatric thyroid programs: a consensus statement. Thyroid. 2025;35(4):346-356. doi:10.1089/thy.2024.0496
  14. Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer. 2014;21(5):T273-T283. doi:10.1530/ERC-14-0053
  15. Denaro N, Romano R, Alfieri S, et al. The tumor microenvironment and the estrogen loop in thyroid cancer. Cancers (Basel). 2023;15(9):2458. doi:10.3390/cancers15092458
  16. Gong Z, Yang S, Wei M, et al. The isoforms of estrogen receptor alpha and beta in thyroid cancer. Front Oncol. 2022;12:916804. doi:10.3389/fonc.2022.916804
  17. Chen W, Song YS, Lee HS, et al. Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene. 2024;43(31):2431-2446. doi:10.1038/s41388-024-03078-1
  18. Slack JC, Hollowell M, Barletta JA. Thyroid nodules and follicular cell–derived thyroid carcinomas in children. Endocr Pathol. 2023;34(2):165-175. doi:10.1007/s12022-023-09764-2
  19. de Sousa MSA, Nunes IN, Christiano YP, Sisdelli L, Cerutti JM. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: systematic review. Rev Endocr Metab Disord. 2024;25(1):35-51. doi:10.1007/s11154-023-09840-2
  20. Rivera JP, Hang JF. Next-generation immunohistochemistry in thyroid neoplasm: a practical review on the applications in diagnosis and molecular classification. Endocr Pathol. 2025;36(1):8. doi:10.1007/s12022-025-09851-6
  21. Liu Y, Bao L, Li G, et al. Identification of oncogenic alterations in 124 cases of pediatric papillary thyroid carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 fusions induce MAPK pathway activation. Endocr Pathol. 2025;36(1):5. doi:10.1007/s12022-025-09850-7
  22. Ali SR, Bryce J, Priego-Zurita AL, et al. Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project. Endocr Connect. 2023;12(12):e230434. doi:10.1530/EC-23-0434